A role for coding functional variants in HNF4A in type 2 diabetes susceptibility

B. Jafar-Mohammadi, C. J. Groves, A. P. Gjesing, B. M. Herrera, W. Winckler, H. M. Stringham, A. P. Morris, T. Lauritzen, A. S. F. Doney, A. D. Morris, M. N. Weedon, A. J. Swift, J. Kuusisto, M. Laakso, D. Altshuler, A. T. Hattersley, F. S. Collins, M. Boehnke, T. Hansen, O. PedersenC. N. A. Palmer, T. M. Frayling, A. L. Gloyn, M. I. McCarthy, DIAGRAM Consortium

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

Aims/hypothesis Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4 alpha (HNF-4A), account for similar to 5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF4A (V255M, minor allele frequency [MAF] similar to 0.1%; T130I, MAF similar to 3.0%)-known to influence downstream HNF-4A target gene expression-are of interest, but previous type 2 diabetes association reports were inconclusive. We aimed to evaluate the contribution of these variants to type 2 diabetes susceptibility through large-scale association analysis.

Methods We genotyped both variants in at least 5,745 cases and 14,756 population controls from the UK and Denmark. We also undertook an expanded association analysis that included previously reported and novel genotype data obtained in Danish, Finnish, Canadian and Swedish samples. A meta-analysis incorporating all published association studies of the T130I variant was subsequently carried out in a maximum sample size of 14,279 cases and 26,835 controls.

Results We found no association between V255M and type 2 diabetes in either the initial (p = 0.28) or the expanded analysis (p = 0.44). However, T130I demonstrated a modest association with type 2 diabetes in the UK and Danish samples (additive per allele OR 1.17 [95% CI 1.08-1.28]; p = 1.5 x 10(-4)), which was strengthened in the meta-analysis (OR 1.20 [95% CI 1.10-1.30]; p = 2.1 x 10(-5)).

Conclusions Our data are consistent with T130I as a low-frequency variant influencing type 2 diabetes risk, but are not conclusive when judged against stringent standards for genome-wide significance. This study exemplifies the difficulties encountered in association testing of low-frequency variants.

Original languageEnglish
Pages (from-to)111-119
Number of pages9
JournalDiabetologia
Volume54
Issue number1
Early online date29 Sep 2010
DOIs
Publication statusPublished - Jan 2011

Keywords

  • HNF4A
  • Low-frequency variants
  • T130I
  • Type 2 diabetes
  • V255M
  • GENOME-WIDE ASSOCIATION
  • NUCLEAR FACTOR 4-ALPHA
  • CHROMOSOME 20Q
  • FACTOR-4-ALPHA GENE
  • COMMON VARIANTS
  • T130I MUTATION
  • UK POPULATION
  • LOCI
  • RISK
  • REPLICATION

Cite this